# FDA Inspection 1269502 - Kandappan Velavan, M.D. - May 02, 2025

Source: https://www.keypedia.com/records/fda_inspections/kandappan-velavan-md/eae28e72-dd46-4433-9966-b87b8d6a8e17
Source feed: FDA_Inspections

> FDA Inspection 1269502 for Kandappan Velavan, M.D. on May 02, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269502
- Company Name: Kandappan Velavan, M.D.
- Inspection Date: 2025-05-02
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1269502 - 2025-05-02](https://www.keypedia.com/records/fda_inspections/kandappan-velavan-md/eaf8f69e-3d5a-4193-af66-fb8dc815b849)

Company: https://www.keypedia.com/companies/kandappan-velavan-md/18921a41-8bb4-4e4f-bf78-5286f013c937

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c